Skip to content

Clinical trials

Completed Phase 3 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 3 Status: Completed Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20034
20044
20053
20063
20072
20086
20093
20103
20115
20121
20135
20142
20151
20161
20172
20183
20192
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion22
United Therapeutics8
Gilead Sciences4
Novartis Pharmaceuticals3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Bayer2
GlaxoSmithKline2
Ain Shams University1
Encysive Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension56
Hypertension, Pulmonary17
Connective Tissue Diseases3
Familial Primary Pulmonary Hypertension2
Hypertension2
Anemia, Sickle Cell1
Angina Pectoris1
Cardiovascular Diseases1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Eisenmenger Complex1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.